The Japan bone densitometer market is expected to record a CAGR of 4.63% during the forecast period, 2022-2028, and is anticipated to reach a revenue of $72.16 million by 2028.

The surging aging population is a key growth driver. As per evaluations, Japan has failed to increase its fertility rate to the replacement levels, attributed to the working culture, traditional gender division of labor, and deteriorating employment opportunities.

To know more about this report, request a free sample copy

In Japan, osteoporosis considerably affects the female population in Japan. As per the International Osteoporosis Function, the aging female population between 50 and 80 constituted 35% of spine injuries, while 9.5% of hip injuries. Whereas the aging male population constitutes 3.8% of the country’s total population.

Further, the total number of hip fractures is expected to reach around 238000 by 2030, according to the International Osteoporosis Foundation. Also, as per the United Nations, almost 35% of the total population is aged above 65. This population segment is increasingly vulnerable to various bone diseases. Additionally, the prevalence of bone injuries and implants in Japan is higher in comparison to other East Asian countries like Vietnam and South Korea. Such aspects increase the demand for bone densitometers in the country.

The Japan bone densitometer market scope includes the segmentation analysis of technology, end-user, and application. The technology segment is sub-categorized into axial bone densitometry and peripheral bone densitometry.

Axial bone densitometry is used to determine osteoporotic fractures of axial skeletal sites like proximal femur, spine, etc. The two methods involved are quantitative computed tomography (QCT) and dual-energy x-ray absorptiometry (DEXA). DEXA uses a minute dose of ionizing radiation to produce pictures of the inside of the body for gauging bone loss. It is non-invasive, quick, and simple, and used for osteoporosis diagnosis to determine the risk of developing osteoporotic fractures. Moreover, it has become the dominant technology used to quantify bone density in clinical practice. Also, minimal radiation is emitted during the whole-body scan.

Whereas QCT calculates the bone mineral density using X-ray computed tomography (CT). It is utilized to create detailed images of internal organs, blood vessels, bones, and soft tissues. It is the most common choice for lumbar spine and hip diagnosis. It was introduced in the 1970s for clinical use. Also, it has higher ionizing radiation than DXA but is favorable compared to other radiographic procedures like spinal radiographs. The technical developments of QCT enable capturing 3D volume images that allow it to be applied to the clinically important site of the proximal femur.

Peripheral Dual Energy X-Ray Absorptiometry (pDEXA) is a photon absorptiometry technique and technology used in peripheral bone densitometry. It is used for diagnosing osteoporosis and assessing fracture risks. It is also used for measuring the bone density in the heel, leg, fingers, and wrist.

Some of the prominent companies operating in the Japan bone densitometer market are Hologic Inc, Oscare Medical OY, Medonica Co Ltd, GE Healthcare, Diagnostic Medical Systems Group, BeamMed Ltd, etc.

Hologic is a global medical technology company that provides cutting-edge solutions. The company’s products encompass GYN surgical health, skeletal & breast health, and diagnostics, emphasizing accurate and early treatment and detection. It operates in 15 countries worldwide, with headquarters in Massachusetts, the United States.

Its key product, Horizon DXA System, is the latest in densitometry technology, and has features for a complete fracture risk assessment. It facilitates the identification of patients at risk of osteoporosis.

Report Synopsis

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.